Ray Therapeutics

RhyGaze

This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.

Atsena

This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.

Vedere

The company develops optogenetics-based gene therapies to restore vision for patients with inherited retinal dystrophies and geographic atrophy.

Eyestem

The company develops cell replacement therapies to treat incurable blindness and retinal diseases for patients globally.

Nightstar

This company develops gene therapies for patients with rare inherited retinal diseases that cause progressive blindness.

Coave Therapeutics

The company develops targeted gene therapies for patients with neurodegenerative and ocular diseases.

Restore Vision

This clinical-stage biotechnology company develops visual restoration gene therapies to treat blindness caused by genetic retinal disorders for patients with retinitis pigmentosa.